x

Search for a clinical trial

* (*) mandatory field

A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy-FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Cytrx corporation
  • Principal investigator of clinical trial

  • Dr Nicolas ISAMBERT
  • Service d'oncologie médicale
  • CLCC Georges-François Leclerc
  • 1 rue professeur Marion - BP 77980
  • 21079 DIJON CEDEX
  • FRANCE
  • More information
  • Phone  : 
    33 (0)3 80 73 75 06 (Secr)
  • Fax  : 33 (0)3 80 73 77 53
  • Website
  • Investigator of clinical trial

  • Pr Claude LINASSIER
  • Service de Cancérologie - Oncologie Médicale
  • Bâtiment B2B, 1er étage - Centre Henry S. Kaplan
  • CHRU de Tours - Hôpital Bretonneau
  • 2 Boulevard Tonnellé
  • 37044 TOURS CEDEX 9
  • FRANCE
  • More information
  • Phone  : 33 (0)2 47 47 99 19
  • Fax  : 33 (0)2 47 47 99 20
  • Website
Last update: July 2015

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.